Alpha 2.0
Login Register
» Authors » Simon Tso

Simon Tso

Explore the profile of Simon Tso including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 34
Citations 107
Followers 0
Related Specialties
Dermatology
Medical Education
Public Health
Top 10 Co-Authors
Aaron Wernham
William Hunt
Vidya Madhwapathi
Lauren Passby
Paul Craig
Neil Rajan
Andrew Ilchyshyn
Kashini Andrew
Richard A Carr
Andrew Zhao
Published In
Clin Exp Dermatol
Clin Teach
Br J Gen Pract
BMJ Case Rep
J Eur Acad Dermatol Venereol
Affiliations
Soon will be listed here.
Recent Articles
1.
Digital Papillary Adenocarcinoma
Haines A, Cooke A, Tso S
Clin Exp Dermatol . 2025 Feb; PMID: 39996317
No abstract available.
2.
Changes in skin research funding: the emergence of environmental sustainability criteria in the research competition assessment process
Badawy H, Harvey J, Rajan N, Stuart B, Tso S
Br J Dermatol . 2024 Dec; PMID: 39703082
No abstract available.
3.
Dermatological societies and their climate change and sustainability commitment through 2024
Niebel D, Tso S, Parker E, Rosenbach M, Tan E, Thio H, et al.
J Eur Acad Dermatol Venereol . 2024 Dec; PMID: 39660563
No abstract available.
4.
Natural progression of basal cell carcinomas in patients awaiting surgical intervention
Lam M, Lam M, Wells H, Zhao A, Gibbs H, Tso S, et al.
Clin Exp Dermatol . 2024 Oct; 50(3):632-634. PMID: 39446979
Basal cell carcinomas (BCCs) are slow-growing keratinocyte tumours. There are few reports in the literature reporting the natural history of untreated BCCs. We evaluated the natural progression of BCCs and...
5.
Is it time for international consensus clinical guidance development for digital papillary adenocarcinoma? : reply to Joshi et al
Tso S, Andrew K, Craig P, Gee B, Unter S, Venables Z, et al.
Clin Exp Dermatol . 2024 Oct; PMID: 39391917
No abstract available.
6.
Appraisal of AI-generated dermatology literature reviews
Passby L, Madhwapathi V, Tso S, Wernham A
J Eur Acad Dermatol Venereol . 2024 Jul; 38(12):2235-2239. PMID: 38994876
Background: Artificial intelligence (AI) tools have the potential to revolutionize many facets of medicine and medical sciences research. Numerous AI tools have been developed and are in continuous states of...
7.
A non-inferiority clinical trial comparing probiotics and oral corticosteroids for the management of acute exacerbation of atopic dermatitis patients
Gamal N, Shoaib M, Farag A, Stark R, Tso S
Skin Health Dis . 2024 Jun; 4(3):e373. PMID: 38846682
A prospective controlled pilot study on the feasibility of utilization of a probiotic mixture for management of acute exacerbation of atopic dermatitis (AD). Patients were allocated to either standard of...
8.
National epidemiology of digital papillary adenocarcinoma in England 2013-2020: a population-based registry study
Andrew K, van Bodegraven B, Vernon S, Balogun M, Craig P, Rajan N, et al.
Clin Exp Dermatol . 2024 May; 49(11):1389-1395. PMID: 38757196
Background: Digital papillary adenocarcinoma (DPA), formerly known as aggressive DPA, is a rare adnexal cancer of sweat gland differentiation with metastatic potential. DPA epidemiology and patient outcome data are prerequisites...
9.
Relative carbon footprint differences between National Institute for Health and Care Excellence melanoma follow-up pathways 2015 and 2022
Grover S, Patel N, Tso S
Clin Exp Dermatol . 2024 Feb; 49(6):633-635. PMID: 38345169
No abstract available.
10.
Aberrant p16, p53 and Ki-67 immunohistochemistry staining patterns can distinguish solitary keratoacanthoma from cutaneous squamous cell carcinoma
Carr R, Mesiano D, Heffron C, Radonic T, Wiggins J, Tso S, et al.
Pathology . 2023 Aug; 55(6):772-784. PMID: 37573161
Keratoacanthoma (KA) is widely considered a benign, usually self-resolving, neoplasm distinct from cutaneous squamous cell carcinoma (cSCC), while some consider KA to be indistinguishable from cSCC. Published studies indicate utility...